Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert E. Bancroft is PRESIDENT & CEO at Aeon Biopharma. OQRO lists 1 transaction filed with the SEC under this name, the latest on Feb 20, 2026, each linked to the official Form 4.
PRESIDENT & CEO
Disclosures on record
1
Companies involved
1
Aeon BiopharmaAEON
Feb 17, 20263Mdisclosed Feb 20
DetailsOfficial recordAs of the latest filing on , Robert E. Bancroft reported holding 3,177,103 shares of Aeon Biopharma (AEON), worth about $486K at the last close of $0 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aeon Biopharma AEON | 3,177,103 | 3.18M direct | $0 | $486K | Feb 17, 2026 |
Is this Robert E. Bancroft’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Feb 17, 2026, Robert E. Bancroft reported holding 3,177,103 shares of Aeon Biopharma (AEON). At the last close of $0 on Nov 13, 2026, that is about $486K. This is the stake disclosed in filings, not a net worth.